European Archives - Page 1009 of 1051 - European Medical Journal

EMJ

Type 1 Diabetes Stunts Brain Growth

CHILDREN with Type 1 diabetes (T1D) have shown slower brain growth than children without the disease. Frequent exposure to hyperglycaemia afflicting…

EMJ

Nature and Nurture Come Together to Trigger Diabetes

THE EPIGENOME has been revealed to play a significant role in diabetes onset, providing clues into how genes and the environment interact…

EMJ

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…

EMJ

New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer…

EMJ

Targeting Monocytes to Help Treat Autoimmune Disorders?

SUPPRESSION of the immune system in fighting diseases could be the fault of a population of white blood cells (WBCs), a group of studies led by…

EMJ

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant…

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?

Due to its increasing prevalence, exceeding 25% of the Western population, non-alcoholic fatty liver disease (NAFLD) merits recognition as one of the…

Alcohol Dependence and Alcoholic Liver Disease

Summary of Presentations from the H. Lundbeck A/S-Supported Symposium, held at the 49th Annual International Liver Congress, London, United Kingdom…

The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014

After genotype 1 (GT1), genotype 3 (GT3) is the second most common hepatitis C virus (HCV) genotype worldwide, with an estimated worldwide prevalence of…

Definitions of Acute-On-Chronic Liver Failure: The Past, the Present, and the Future

Acute-on-chronic liver failure (ACLF) is an entity used to define patients with liver cirrhosis presenting with acute decompensation.